Literature DB >> 11904411

Protein-protein interactions monitored in mammalian cells via complementation of beta -lactamase enzyme fragments.

Tom Wehrman1, Benjamin Kleaveland, Jeng-Horng Her, Robert F Balint, Helen M Blau.   

Abstract

We have defined inactive alpha and omega fragments of beta-lactamase that can complement to form a functional enzyme in both bacteria and mammalian cells, serving as a readout for the interaction of proteins fused to the fragments. Critical to this advance was the identification of a tripeptide, Asn-Gly-Arg, which when juxtaposed at the carboxyl terminus of the alpha fragment increased complemented enzyme activity by up to 4 orders of magnitude. beta-Lactamase is well suited to monitoring constitutive and inducible protein interactions because it is small (29 kDa), monomeric, and assayable with a fluorescent cell-permeable substrate. The negligible background, the magnitude of induced signal caused by enzymatic amplification, and detection of signal within minutes are unparalleled in mammalian protein interaction detection systems published to date.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11904411      PMCID: PMC122547          DOI: 10.1073/pnas.062043699

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

Review 1.  Interaction blues: protein interactions monitored in live mammalian cells by beta-galactosidase complementation.

Authors:  F M Rossi; B T Blakely; H M Blau
Journal:  Trends Cell Biol       Date:  2000-03       Impact factor: 20.808

2.  Cell proliferation through forced engagement of c-Kit and Flt-3.

Authors:  K G Otto; L Jin; D M Spencer; C A Blau
Journal:  Blood       Date:  2001-06-01       Impact factor: 22.113

3.  Epidermal growth factor receptor dimerization monitored in live cells.

Authors:  B T Blakely; F M Rossi; B Tillotson; M Palmer; A Estelles; H M Blau
Journal:  Nat Biotechnol       Date:  2000-02       Impact factor: 54.908

4.  Kinetic mechanism of metallo-beta-lactamase L1 from Stenotrophomonas maltophilia.

Authors:  S McManus-Munoz; M W Crowder
Journal:  Biochemistry       Date:  1999-02-02       Impact factor: 3.162

5.  Controlled dimerization of ErbB receptors provides evidence for differential signaling by homo- and heterodimers.

Authors:  S K Muthuswamy; M Gilman; J S Brugge
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

6.  A novel genetic system to detect protein-protein interactions.

Authors:  S Fields; O Song
Journal:  Nature       Date:  1989-07-20       Impact factor: 49.962

7.  Fluorescence ratio imaging of cyclic AMP in single cells.

Authors:  S R Adams; A T Harootunian; Y J Buechler; S S Taylor; R Y Tsien
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

8.  Erythropoietin receptor activation by a ligand-induced conformation change.

Authors:  I Remy; I A Wilson; S W Michnick
Journal:  Science       Date:  1999-02-12       Impact factor: 47.728

9.  Crystal structure of Escherichia coli TEM1 beta-lactamase at 1.8 A resolution.

Authors:  C Jelsch; L Mourey; J M Masson; J P Samama
Journal:  Proteins       Date:  1993-08

10.  A mammalian protein targeted by G1-arresting rapamycin-receptor complex.

Authors:  E J Brown; M W Albers; T B Shin; K Ichikawa; C T Keith; W S Lane; S L Schreiber
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

View more
  50 in total

1.  Monitoring protein-protein interactions using split synthetic renilla luciferase protein-fragment-assisted complementation.

Authors:  R Paulmurugan; S S Gambhir
Journal:  Anal Chem       Date:  2003-04-01       Impact factor: 6.986

2.  Noninvasive imaging of protein-protein interactions in living subjects by using reporter protein complementation and reconstitution strategies.

Authors:  R Paulmurugan; Y Umezawa; S S Gambhir
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-18       Impact factor: 11.205

3.  Molecular imaging of drug-modulated protein-protein interactions in living subjects.

Authors:  Ramasamy Paulmurugan; Tarik F Massoud; Jing Huang; Sanjiv S Gambhir
Journal:  Cancer Res       Date:  2004-03-15       Impact factor: 12.701

Review 4.  Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system.

Authors:  Bram Stynen; Hélène Tournu; Jan Tavernier; Patrick Van Dijck
Journal:  Microbiol Mol Biol Rev       Date:  2012-06       Impact factor: 11.056

5.  Kinetics and reaction coordinates of the reassembly of protein fragments via forward flux sampling.

Authors:  Ernesto E Borrero; Lydia M Contreras Martínez; Matthew P DeLisa; Fernando A Escobedo
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

6.  Firefly luciferase enzyme fragment complementation for imaging in cells and living animals.

Authors:  Ramasamy Paulmurugan; Sanjiv S Gambhir
Journal:  Anal Chem       Date:  2005-03-01       Impact factor: 6.986

7.  Novel fusion protein approach for efficient high-throughput screening of small molecule-mediating protein-protein interactions in cells and living animals.

Authors:  Ramasamy Paulmurugan; Sanjiv S Gambhir
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

8.  A system for quantifying dynamic protein interactions defines a role for Herceptin in modulating ErbB2 interactions.

Authors:  T S Wehrman; W J Raab; C L Casipit; R Doyonnas; J H Pomerantz; H M Blau
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-05       Impact factor: 11.205

Review 9.  Reporter gene imaging of protein-protein interactions in living subjects.

Authors:  Tarik F Massoud; Ramasamy Paulmurugan; Abhijit De; Pritha Ray; Sanjiv S Gambhir
Journal:  Curr Opin Biotechnol       Date:  2007-01-24       Impact factor: 9.740

Review 10.  Visualization of molecular interactions using bimolecular fluorescence complementation analysis: characteristics of protein fragment complementation.

Authors:  Tom K Kerppola
Journal:  Chem Soc Rev       Date:  2009-09-04       Impact factor: 54.564

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.